ANGO Market Analysis
News & Sentiment
49 articles · sorted by datePage 1 of 3 · 49 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—Forward 96.15
EPS (TTM)$-0.880.0% YoY
Profit margin-11.5%HEALTHCARE
Market cap$611.3MSmall cap
Valuation
- Forward P/E
- 96.15
- PEG ratio
- 1.41
- P/B
- 3.57
- P/S (TTM)
- 1.91
- EV/EBITDA
- 911.69
Profitability & growth
- ROE (TTM)
- -20.8%
- Operating margin
- -6.5%
- Revenue growth YoY
- 8.0%
- Dividend yield
- —
- Beta
- 0.34
Last earnings
Jul 14, 2026 · Estimate $-0.11 · Reported $-0.07
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About AngioDynamics Inc
Company profileAngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company is headquartered in Latham, New York.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 14 PLAZA DRIVE, LATHAM, NY
- Fiscal year end
- May
- Latest quarter
- May 31, 2026
Market cap$611.3M
Shares outstanding$41.3M
52W high$15.20
52W low$8.36
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent